EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance

Bingli Wu, Yinwei Cheng, Liyan Li, Zepeng Du, Qianlou Liu, Xinyue Tan, Xin Li, Guozhi Zhao, Enmin Li

Drug Resistance Updates · 2025

DOI: 10.1016/j.drup.2025.101238 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025. Verfasst von Bingli Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong Province 515041, China; Chaoshan Branch of S…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Antineoplastic Agents, Reactive Oxygen Species. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 240 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapeutic drug resistance remains a major barrier to effective cancer treatment. Drug resistance could be driven in part by adaptive redox remodeling of cancer cells. Paradoxically, drug-resistant malignancies exhibit elevated reactive oxygen species (ROS), as well as amplified antioxidant defenses, which enable cancer cell survival under therapeutic stress. Central to this adaptation is glutathione (GSH), the predominant cellular antioxidant, whose synthesis relies on sulfur-containing amino acids (SAAs) - methionine and cysteine. This review delineates the metabolic interplay between methionine and cysteine in the transsulfuration pathway, highlighting their roles as precursors in GSH biosynthesis. We systematically summarize the key enzymes that drive GSH production and their contributions to resistance against platinum-based drugs and other chemotherapeutics. In addition to GSH synthesis, we summarize the roles of GSH antioxidant systems, including glutathione peroxidases (GPXs), peroxiredoxins (PRDXs), and thioredoxins (TRXs), which are critical in chemotherapeutic drug resistance through ROS scavenging. Recent advances reveal that targeting these enzymes, by pharmacologically inhibiting transsulfuration enzymes or disrupting GSH-dependent antioxidant cascades, can sensitize resistant cancer cells to ROS-mediated therapies. These findings not only clarify the mechanistic links between SAA metabolism and redox adaptation but also provide practical approaches to overcome chemotherapeutic drug resistance. By analyzing metabolic and redox vulnerabilities, this review highlights the therapeutic potential to restore chemosensitivity, offering new options in precision oncology medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsAntineoplastic AgentsReactive Oxygen SpeciesHumansGlutathioneAntioxidantsAnimalsMethionineCysteineOxidation-Reduction

Stichwörter der Autor:innen

Antioxidant proteinsChemotherapeutic drug resistanceReactive oxygen species

Substanzen

Antineoplastic AgentsGlutathioneReactive Oxygen SpeciesAntioxidantsMethionineCysteine

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong Province 515041, China; Chaoshan Branch of State Key Laboratory for Esophageal Cancer Prevention and Treatment, Ca…
  • Department of Critical Care Medicine, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangd…
  • Department of Central Laboratory, Shantou Central Hospital, Shantou, Guangdong 515041, China.
  • Department of Urology Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: 494475057@qq.com.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Wu, B., Cheng, Y., Li, L., Du, Z., Liu, Q., Tan, X., Li, X., Zhao, G., & Li, E. (2025). Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101238

Vancouver

Wu B, Cheng Y, Li L, Du Z, Liu Q, Tan X, et al. Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance. Drug Resistance Updates. 2025. doi:10.1016/j.drup.2025.101238

BibTeX
@article{Wu2025,
  author = {Wu, Bingli and Cheng, Yinwei and Li, Liyan and Du, Zepeng and Liu, Qianlou and Tan, Xinyue and Li, Xin and Zhao, Guozhi and Li, Enmin},
  title = {Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance},
  journal = {Drug Resistance Updates},
  year = {2025},
  doi = {10.1016/j.drup.2025.101238}
}
Kostenlos starten →